MedPath

Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy (SECRET) Study: Development of Patient Selection Criteria Using CT Images and Accompanying Diseases for Efficient Intravenous Thrombolytic and Intra-arterial Recanalization Therapy in Acute Ischemic Stroke

Completed
Conditions
Ischemic Stroke
Interventions
Other: Brain CT imaging
Registration Number
NCT02964052
Lead Sponsor
Yonsei University
Brief Summary

Use of intravenous (IV) thrombolysis and intra-arterial (IA) recanalization treatment has been rapidly increasing, However, despite of the treatment, recanalization rates are 22.6 - 70% and only 30-50% of patients show meaningful clinical improvements. Mechanisms of futile recanalization may include 1) large ischemic core, 2) poor collateral, and 3) presence of comorbidity. In this regards, developing selection criteria using acute stroke imaging and comorbidity is warranted.

Investigators will recruit the consecutive acute stroke patients who received IV thrombolysis and/or IA recanalization treatment. This study will perform with prospective design to develop CT-based clot, core and collateral scores and a comorbidity index for selecting stroke patients who are at high risks by the treatment. Investigators will firstly establish the CT-based scores and comorbidity index using a pre-existing cohort database. Using these CT-based and comorbidity index, Investigators will validate them in a multi-center prospectively cohort. In addition, Investigators will assess the cost-effectiveness of selecting patients based on the comorbidity index.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1359
Inclusion Criteria
  • Age ≥20 years old
  • Acute ischemic stroke patients who underwent CT angiographies before IV thrombolysis and/or IA recanalization treatment
  • Patients who give an informed consents for participation in the study or the legal representative or immediate family give informed consent on behalf of patients in case of difficulty to decide study enrollment.
Read More
Exclusion Criteria
  • Age <20 years old
  • Acute ischemic stroke patients who did not receive IV thrombolysis and/or IA recanalization treatment
  • No informed consents from patients
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Acute ischemic stroke patientsBrain CT imagingAcute ischemic stroke patients who received intravenous (IV) thrombolysis and/or intra-arterial (IA) recanalization treatment
Primary Outcome Measures
NameTimeMethod
Death6 months after discharge day
Recanalization rateafter 32 hrs thrombolytic treatments in MRA, CTA, or digital subtraction angiography (DSA)
asymptomatic hemorrhagic transformation rateafter 32 hrs thrombolysis in MR or CT
Modified Rankin scale scores3 months after discharge day
Symptomatic hemorrhagic transformation rateafter 32 hrs thrombolytic treatments in MR or CT
National Institutes of Health Stroke Scale (NIHSS) scores1 hr after IV rt-PA infusion
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Neurology, Yonsei University College of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath